| Journal | Experimental and clinical psychopharmacology |
| Study Type | Clinical Study |
| Population | Human participants |
This behavioral economics approach addresses a fundamental clinical challenge: patients often reduce substance use more successfully when they have meaningful alternative activities rather than focusing solely on cessation. The substance-free activity session (SFAS) model offers clinicians a structured framework for helping patients identify and engage in rewarding non-substance activities.
This narrative review examined 15 studies evaluating the SFAS intervention, which combines behavioral economic principles with motivational interviewing to enhance goal-directed activities as alternatives to substance use rewards. The approach showed efficacy when integrated with standard brief interventions, particularly in college populations. The intervention focuses on identifying and scheduling pleasant, meaningful activities rather than solely targeting substance reduction. Limitations include the concentration of evidence in college students and the need for more diverse population studies.
“I find this approach clinically sensible because it addresses what I see regularly in practice—patients struggle more with the void left by reduced substance use than with the reduction itself. Helping patients proactively build rewarding substance-free activities feels more sustainable than harm-focused interventions alone.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is the Substance-Free Activity Session (SFAS) approach and how does it work?
- How effective is SFAS compared to standard brief interventions for substance use?
- Can SFAS be used specifically for cannabis use disorders?
- What makes SFAS potentially more appealing to patients than traditional substance use treatments?
- What is the current evidence level for implementing SFAS in clinical practice?
FAQ
What is the Substance-Free Activity Session (SFAS) approach and how does it work?
SFAS is an intervention that combines behavioral economics and motivational interviewing to help individuals develop rewarding activities that can serve as alternatives to substance use. It focuses on enhancing goal-directed and mood-enhancing activities rather than solely focusing on reducing substance use, providing positive reinforcement pathways that compete with drug and alcohol rewards.
How effective is SFAS compared to standard brief interventions for substance use?
Research shows SFAS demonstrates efficacy when integrated with standard brief alcohol interventions, particularly for college students. While standard brief interventions have reliable but small effect sizes, SFAS may enhance treatment outcomes by addressing wellness, mood, and goal pursuit in addition to substance use reduction.
Can SFAS be used specifically for cannabis use disorders?
Yes, SFAS can be applied to cannabis use disorders as part of a comprehensive treatment approach. The intervention’s focus on developing substance-free rewarding activities and enhancing motivation for behavior change makes it suitable for addressing various substance use patterns, including problematic cannabis use.
What makes SFAS potentially more appealing to patients than traditional substance use treatments?
SFAS may have broader appeal because it emphasizes positive lifestyle changes, wellness enhancement, and goal achievement rather than focusing primarily on substance use problems. This approach may attract individuals who might otherwise avoid traditional treatment due to stigma or resistance to acknowledging substance use issues.
What is the current evidence level for implementing SFAS in clinical practice?
The evidence for SFAS is considered early-stage with monitored relevance, requiring further research before widespread clinical implementation. While 15 empirical studies support its efficacy and mechanisms, more robust evidence is needed to establish it as a standard treatment approach for substance use disorders.